The Cybersecurity and Infrastructure Security Agency is tracking an unknown malicious cyber actor who is spoofing the Small Business Administration COVID-19 loan relief webpage via phishing emails, the agency announced yesterday.

Sent to various recipients in the Federal Civilian Executive Branch and state, local, tribal and territorial government, the emails include a malicious link to the spoofed SBA website that the cyber actor is using for malicious re-directs and credential stealing, the agency said.

For details, including recommended mitigation actions and other resources, see the CISA alert.

“As we can see, heinous COVID-19-themed fraud schemes continue to perpetuate, and the common denominator seems to be enticing unsuspecting victims to provide funds, passwords or personal identifying information,” said John Riggi, AHA senior advisor for cybersecurity and risk. “To mitigate these threats, educate staff, always independently verify solicitations (even from ‘trusted’ sources), never provide down payments for PPE without verification and reputable references, and be suspect of any solicitations that claim to be affiliated with a government agency.’”

Related News Articles

Headline
Microsoft July 22 released an update on the ongoing cyberattacks to SharePoint servers used within organizations, attributing the incidents to China-based…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency, Department of Health and Human Services, and Multi-State Information Sharing and Analysis Center…
Headline
Microsoft July 19 issued an alert about active attacks from vulnerabilities targeting SharePoint servers used within organizations. The incidents have not…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
In his latest AHA Cyber and Risk Intel blog, Scott Gee, AHA deputy national advisor for cybersecurity and risk, explains how hospitals can prepare for and…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…